日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The legacy of a gentleman scientist: Pierre Hainaut

一位绅士科学家的遗产:皮埃尔·埃诺

Arnoult, Christophe; Attardi, Laura D; Batsheva, Kerem; Blandino, Giovanni; Burns, Kathleen H; Del Sal, Giannino; Kirsch, David G; Lane, David P; Levine, Arnold J; Lozano, Guillermina; Malkin, David; Melino, Gerry; Oren, Moshe; Prives, Carol; Schramek, Daniel

Elucidating cooperative genetic events in DCIS progression in mutant p53-driven breast cancer.

阐明突变型 p53 驱动的乳腺癌中 DCIS 进展的协同遗传事件。

Morrissey Rhiannon L, McDaniel Joy M, Chau Gilda P, Su Xiaoping, V Mitheera, Chandra Vidhi, Dixon Beverly R E A, El-Naggar Adel K, Thompson Alastair M, Lozano Guillermina

Mutant p53 Gain of Function: Why Many See It, Why Some Do Not

p53突变获得功能:为什么很多人能看到它,而有些人却看不到?

Lozano, Guillermina; Prives, Carol; Sabapathy, Kanaga

Restoration of the Tumor Suppressor Function of Y220C-Mutant p53 by Rezatapopt, a Small-Molecule Reactivator.

Rezatapopt(一种小分子激活剂)可恢复 Y220C 突变 p53 的肿瘤抑制功能

Puzio-Kuter Anna M, Xu Lizhong, McBrayer Mary Kate, Dominique Romyr, Li Hongju H, Fahr Bruce J, Brown Alyssa M, Wiebesiek Amy E, Russo Brandon M, Mulligan Chris L, Yang Hong, Battaglia Josh, Robell Kimberly A, Thomas Dafydd H, Huang Kuo-Sen, Solovyov Alexander, Greenbaum Benjamin D, Oliner Jonathan D, Davis Thomas W, Dumble Melissa L, Johnson Melissa L, Xiong Shunbin, Yang Peirong, Lozano Guillermina, Fellous Marc M, Vu Binh T, Schram Alison M, Levine Arnold J, Poyurovsky Masha V

Dependence on Mdm2 for Mdm4 inhibition of p53 activity

Mdm4对p53活性的抑制依赖于Mdm2

Xiong, Shunbin; Zhang, Yun; Zhou, Xin; Pant, Vinod; Mirani, Akshita; Gencel-Augusto, Jovanka; Chau, Gilda; You, M James; Lozano, Guillermina

Stromal fibroblastic mutant Trp53 promotes mammary tumor development via enhanced secretion of paracrine factors

基质成纤维细胞突变体Trp53通过增强旁分泌因子的分泌促进乳腺肿瘤的发生发展

Liu, Bin; Xiong, Shunbin; Williams-Villalobo, Abie; Chau, Gilda; Qi, Yuan; Chen, Hehua; Johnson, Carenza; Chachad, Dhruv; McDaniel, Joy; Su, Xiaoping; El-Naggar, Adel K; Lozano, Guillermina; Zhang, Yun

Inhibition of ULK1/2 and KRAS (G12C) controls tumor growth in preclinical models of lung cancer

抑制ULK1/2和KRAS(G12C)可控制肺癌临床前模型中的肿瘤生长

Ghazi, Phaedra C; O'Toole, Kayla T; Srinivas Boggaram, Sanjana; Scherzer, Michael T; Silvis, Mark R; Zhang, Yun; Bogdan, Madhumita; Smith, Bryan D; Lozano, Guillermina; Flynn, Daniel L; Snyder, Eric L; Kinsey, Conan G; McMahon, Martin

Tissue specificity and spatio-temporal dynamics of the p53 transcriptional program

p53转录程序的组织特异性和时空动态

Pant, Vinod; Sun, Chang; Lozano, Guillermina

Triple-negative breast tumors are dependent on mutant p53 for growth and survival

三阴性乳腺肿瘤的生长和存活依赖于突变型p53。

Dibra, Denada; Moyer, Sydney M; El-Naggar, Adel K; Qi, Yuan; Su, Xiaoping; Lozano, Guillermina

Is loss of p53 a driver of ductal carcinoma in situ progression?

p53 的缺失是导管原位癌进展的驱动因素吗?

Morrissey, Rhiannon L; Thompson, Alastair M; Lozano, Guillermina